Keurig Dr Pepper stock has delivered a 15.5% return year to date, yet its valuation checks and market multiples suggest the shares are not an obvious bargain at current levels.

• Year to date, Keurig Dr Pepper is up 15.5%, which puts more pressure on the current share price to be backed by solid fundamentals.
• Planned separation into Beverage Co. and Global Coffee Co., along with the appointment of Cardinal Health CFO Aaron Alt to the board, may support execution and capital allocation. However, any disruption from the split process could weigh on how investors price the stock.
• With only 2 of 6 valuation checks screening as attractive, Keurig Dr Pepper currently leans expensive rather than clearly cheap on the broader metrics.

The issue now is whether the recent share price strength leaves enough upside in Keurig Dr Pepper to justify paying what looks like a fuller valuation.

Has Keurig Dr Pepper Run Too Far on Earnings?

The P/E ratio is a useful way to think about what you are paying today for each dollar of Keurig Dr Pepper earnings. On this measure, the stock trades at about 32.4x, which is above both the Beverage industry average of roughly 16.9x and the peer group average of about 25.6x.

The fair P/E ratio estimate for Keurig Dr Pepper is about 25.4x based on its sector, margins, size and risk profile. That is a clear gap versus the current 32.4x, which implies investors are already paying a premium to what this framework would suggest. Despite the upcoming split into Beverage Co. and Global Coffee Co. and the appointment of Aaron Alt to the board helping sentiment, the current multiple still prices Keurig Dr Pepper at a premium to peers and the tailored fair value benchmark.

On the P/E multiple, Keurig Dr Pepper stock currently screens as overvalued.

The Keurig Dr Pepper Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Keurig Dr Pepper act as the bridge from this valuation puzzle, since they spell out which future outcomes for growth, margins and earnings would need to hold for the stock to be worth materially more or less than today's price on the Community page. Rather than a single multiple or model output, each one lays out the assumptions behind its view of fair value so you can compare those expectations with the results Keurig Dr Pepper actually delivers over time.

You can be one of the early voices in the Simply Wall St community to set out a number driven Narrative on Keurig Dr Pepper, weighing in on whether the planned split and Aaron Alt's appointment help support the current valuation.

Share your view in a Narrative today and track how your thesis on Keurig Dr Pepper's earnings, margins and execution holds up as new results arrive.

Do you think there's more to the story for Keurig Dr Pepper? Head over to our Community to see what others are saying!

The Bottom Line

Keurig Dr Pepper now screens as overvalued on market multiples, with the current P/E sitting above both industry and tailored fair value benchmarks. That does not rule out further gains; however, it does mean the bar is higher for future execution to support today’s pricing. The crux for investors is whether the planned split and management changes translate into earnings and margin delivery that keeps the premium multiple intact, or whether the valuation settles closer to peers if those expectations soften.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.